Dr. Nadia Cheaib, PharmD, PhDc France – Founder

Before starting-up ClinServ in France, Nadia Cheaib worked
for over 12 years in Clinical Research within Western Europe
(France, UK, Belgium). Including positions as Clinical Research
Scientist, Head of Quality Assurance (Biotrial France),
Head of Medical Writing and Regulatory Affairs (Biotrial, France),
Clinical Research Consultant (Pharm-Olam, UK) and Publications
Coordinator Consultant (GSK, Belgium).

During this time, she developed a Quality Assurance System for
Preclinical and Clinical Trials units and Safety Laboratory, according to
GCP and GLP international guidelines and French regulatory.
She also set-up and managed Medical Writing and Regulatory
Affairs Unit according to ICH and EU requirements.

Since 2007, she is the president of the Middle East Clinical Research
Association MECRA.

Back to top

Welcome to ClinServ International, your professional Contract Research
Organization operating in the European Union and the Middle East.

We are happy to provide Clinical Research Services based on strong medical and pharmaceutical knowledge; long expertise in international clinical trials (American,
European and the Middle East); all according to international quality standards (ICH GCP).
ClinServ foundational and operational principles are:

Produce and ensure high quality results in all the tasks we undertake.
Develop real partnerships with our clients.
Provide expertise our clients can rely on.
Offer our clients with the best benefits for their projects
Openness and transparency in all our relationships

We have established many successful partnership projects with International
Pharmaceuticals Companies, major University Hospitals and CROs.

Based on our history of networking and collaboration with different
companies, researchers and provider on this field, we would be happy
to provide an excellent service for your needs. On worldwide scale,
with a truly proactive team, ClinServ will ensure your project runs
smoothly, and meets your targets and milestones.

We are proud to offer you a very strong know-how of conducting
clinical trials according to ICH-GCP as we have been applying it for
the past 12 years in Western Countries and actually in the Middle
East region. This makes us an excellent interface between
Western Sponsors and Local Investigators. In addition,
the high level of qualification and language fluency of our team
can assure confidence and high professional exchange with investigators.

Please do not hesitate to ask for more information about our
services, our CVs, or for a free cost-estimate. Be assured
that we will be as passionate about your projects as you are!
I thank you for taking the time to read this communication
and I hope we have the pleasure of collaborating with you soon.

Dr. Nadia Cheaib
PharmD, PhDc, MSc, DVP; Rennes - France
Chairman

• Neurology (Parkinson, Alzheimer and Lewy Body Dementia): 3 studies, all Phase 3
• Nuclear Medecine: 1 study, Phase 3
• Hepatic Transplantation: 1 study, Phase 3
• Dermatology (Onychomycosis): 2 studies, Phase 3
• Ophthalmology (Glaucoma): 2 studies, Phase 3
• Infectious Disease, anti-viral (HIV): 2 studies, Phase 1
• Infectious Disease, Ventilation associated Pneumonia: Phase 3
• Urology, Lithotripsy: 1 local study, Phase 2
• Infectious Disease, Antibiotics: 5 studies, Phase 1 & 2
• Infectious Disease: 3 Bioequivalence studies
• Oncology: 8 studies, Phase 1-2
• Diabetes: 2 post marketing studies
• Cardiology, Hypertension, CHF: 2 studies in phase 3, 3 post marketing studies.

Geographical Areas We Cover

Europe:                                              France, Belgium

Mediterranean & Arab World:     Lebanon, Syria, Jordan, Egypt, Turkey, Greece, Cyprus, United Arab Emirates (Qatar, Dubai), Kingdom of Saudi Arabia, Oman, Kuwait, Bahrain, Tunisia, Algeria, Morocco.